This inventor holds 1 USPTO granted patent and 3 published patent applications and 3 EPO patents. Top assignee: Acerus Pharmaceuticals USA, LLC. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Seymour Fein: Innovator in Safe Desmopressin Administration
Introduction
Seymour Fein is a notable inventor based in New Canaan, CT (US). He has made significant contributions to the field of medicine, particularly in the administration of desmopressin. His innovative approach aims to enhance patient safety and comfort.
Latest Patents
Fein holds a patent for a family of intranasal spray dispensers designed for administering uniform low doses of desmopressin. This invention is crucial for achieving safe antidiuresis in human patients. The dispensers can be utilized in treating various conditions, including nocturia, primary nocturnal enuresis, incontinence, urinary frequency, and diabetes insipidus. The invention also addresses situations where desmopressin therapy is beneficial, promoting health effects and improving voiding control.
Career Highlights
Throughout his career, Seymour Fein has worked with several prominent companies in the pharmaceutical industry. Notably, he has been associated with Acerus Pharmaceuticals USA, LLC and Serenity Pharmaceuticals LLC. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.
Collaborations
(Section skipped due to space constraints.)
Conclusion
Seymour Fein's contributions to the field of desmopressin administration highlight his commitment to improving patient care through innovation. His work continues to influence the medical community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile